{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:27:05Z","timestamp":1792502825822,"version":"4.5.0"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1097\/aud.0b013e3181e8b6a7","type":"journal-article","created":{"date-parts":[[2010,7,12]],"date-time":"2010-07-12T06:36:36Z","timestamp":1278916596000},"page":"61-74","source":"Crossref","is-referenced-by-count":60,"title":["Distortion-Product Otoacoustic Emission Test Performance for Ototoxicity Monitoring"],"prefix":"10.1097","volume":"32","author":[{"given":"Kelly M.","family":"Reavis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garnett","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Gallun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Fausti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy J.","family":"Helt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Konrad-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210128","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1001\/archinte.160.21.3252","article-title":"Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use.","volume":"160","author":"Agha","year":"2000","journal-title":"Arch Intern Med"},{"key":"R2-8-20210128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.2930160203","article-title":"Auditory toxicity effects of long-term cis-dichloro-diammineplatinum II therapy in genitourinary cancer patients.","volume":"16","author":"Aguilar-Markulis","year":"1981","journal-title":"J Surg Oncol"},{"key":"R3-8-20210128","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0378-5955(99)00211-7","article-title":"Cisplatin-inducted apoptotic cell death in Mongolian gerbil cochlea.","volume":"141","author":"Alam","year":"2000","journal-title":"Hear Res"},{"key":"R4-8-20210128","first-page":"369","article-title":"Health literacy, communication, and treatment decision-making in older cancer patients.","volume":"23","author":"Amalraj","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"R5-8-20210128","first-page":"1","article-title":"American Academy of Audiology Position Statement and Clinical Practice Guidelines: Ototoxicity Monitoring","year":"2009"},{"key":"R6-8-20210128","article-title":"American National Standard Specification for Audiometers. ANSI S3.6-1989.","year":"1989"},{"key":"R7-8-20210128","first-page":"11","article-title":"Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy.","volume":"36","year":"1994","journal-title":"ASHA"},{"key":"R8-8-20210128","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0196-0709(86)80050-3","article-title":"Cisplatin: Evaluation of its ototoxic potential.","volume":"7","author":"Anniko","year":"1986","journal-title":"Am J Otolaryngol"},{"key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archotol.125.2.215","article-title":"High frequency hearing influences lower-frequency distortion-product otoacoustic emissions.","volume":"125","author":"Arnold","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R10-8-20210128","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/archotol.1994.01880290051009","article-title":"Risk factors for ototoxicity due to cisplatin.","volume":"120","author":"Blakley","year":"1994","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R11-8-20210128","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00003446-198708000-00003","article-title":"Synergistic interactions of noise and other ototraumatic agents.","volume":"8","author":"Boettcher","year":"1987","journal-title":"Ear Hear"},{"key":"R12-8-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00464398","article-title":"Cisplatin-induced ototoxicity: Audiometric findings and experimental cochlear pathology.","volume":"242","author":"Boheim","year":"1985","journal-title":"Arch Otorhinolaryngol"},{"key":"R13-8-20210128","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bjc.1998.226","article-title":"Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.","volume":"77","author":"Bokemeyer","year":"1998","journal-title":"Br J Cancer"},{"key":"R14-8-20210128","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2165\/00003495-198019060-00002","article-title":"Drug-induced ototoxicity.","volume":"19","author":"Brummett","year":"1980","journal-title":"Drugs"},{"key":"R15-8-20210128","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0030-6665(20)30774-X","article-title":"Audiologic monitoring for ototoxicity.","volume":"26","author":"Campbell","year":"1993","journal-title":"Otolaryngol Clin North Am"},{"key":"R16-8-20210128","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1044\/jshd.2404.330","article-title":"Preferred method for clinical determination of pure-tone thresholds.","volume":"24","author":"Carhart","year":"1959","journal-title":"J Speech Hear Disord"},{"key":"R17-8-20210128","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.21683","article-title":"Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.","volume":"106","author":"Chen","year":"2006","journal-title":"Cancer"},{"key":"R18-8-20210128","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/geront\/43.5.661","article-title":"The impact of hearing loss on quality of life in older adults.","volume":"43","author":"Dalton","year":"2003","journal-title":"Gerontologist"},{"key":"R19-8-20210128","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3766\/jaaa.19.4.5","article-title":"Influence of ultrahigh-frequency hearing thresholds on distortion-product otoacoustic emission levels at conventional frequencies.","volume":"19","author":"Dreisbach","year":"2008","journal-title":"J Am Acad Audiol"},{"key":"R20-8-20210128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00003446-199904000-00006","article-title":"Predicting audiometric status from distortion product otoacoustic emissions using multivariate analyses.","volume":"20","author":"Dorn","year":"1999","journal-title":"Ear Hear"},{"key":"R21-8-20210128","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/019459988108900424","article-title":"Cis-diamminedichloroplatinum (II) ototoxicity in the guinea pig.","volume":"89","author":"Estrem","year":"1981","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R22-8-20210128","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1121\/1.383643","article-title":"A system for evaluating auditory function from 8000-20 000 Hz.","volume":"66","author":"Fausti","year":"1979","journal-title":"J Acoust Soc Am"},{"key":"R23-8-20210128","first-page":"162","article-title":"Reliability and validity of high frequency (8-20 kHz) thresholds obtained on a computer-based audiometer as compared to a documented laboratory system.","volume":"1","author":"Fausti","year":"1990","journal-title":"J Am Acad Audiol"},{"key":"R24-8-20210128","first-page":"166","article-title":"Portable stimulus generator for obtaining high-frequency (8-14 kHz) auditory brainstem responses.","volume":"3","author":"Fausti","year":"1992","journal-title":"J Am Acad Audiol"},{"key":"R25-8-20210128","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00003446-199912000-00005","article-title":"An individualized, sensitive frequency range for early detection of ototoxicity.","volume":"20","author":"Fausti","year":"1999","journal-title":"Ear Hear"},{"key":"R26-8-20210128","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0040-1715935","article-title":"Early detection of ototoxicity using 1\/6th-octave steps.","volume":"14","author":"Fausti","year":"2003","journal-title":"J Am Acad Audiol"},{"key":"R27-8-20210128","article-title":"Applied Longitudinal Analysis.","author":"Fitzmaurice","year":"2004"},{"key":"R28-8-20210128","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00000421-198508000-00005","article-title":"Ototoxicity from cis-platinum in patients with stages III and IV previously untreated squamous cell cancer of the head and neck.","volume":"8","author":"Fleming","year":"1985","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"R29-8-20210128","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1121\/1.406691","article-title":"Otoacoustic emissions from normal-hearing and hearing-impaired subjects: Distortion product responses.","volume":"93","author":"Gorga","year":"1993a","journal-title":"J Acoust Soc Am"},{"key":"R30-8-20210128","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1121\/1.407348","article-title":"A comparison of transient-evoked and distortion product ototacoustic emissions in normal-hearing and hearing-impaired subjects.","volume":"94","author":"Gorga","year":"1993b","journal-title":"J Acoust Soc Am"},{"key":"R31-8-20210128","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00003446-199712000-00003","article-title":"From laboratory to clinic: A large scale study of distortion product otoacoustic emissions in ears with normal hearing and ears with hearing loss.","volume":"18","author":"Gorga","year":"1997","journal-title":"Ear Hear"},{"issue":"2","key":"R32-8-20210128","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1121\/1.416208","article-title":"The use of cumulative distributions to determine critical values and levels of confidence for clinical distortion product ototacoustic emission measurements.","volume":"100","author":"Gorga","year":"1996","journal-title":"J Acoust Soc Am"},{"key":"R33-8-20210128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-5955(90)90046-R","article-title":"Interaction of cisplatin and noise on the peripheral auditory system.","volume":"50","author":"Gratton","year":"1990","journal-title":"Hear Res"},{"key":"R34-8-20210128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve.","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"R35-8-20210128","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/14656566.4.6.889","article-title":"Toxicity of platinum compounds.","volume":"4","author":"Hartmann","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"R36-8-20210128","first-page":"269","article-title":"Swallowing Intervention in Oncology","author":"Hodges","year":"1999"},{"key":"R37-8-20210128","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0194-5998(98)70276-1","article-title":"Histopathology of human temporal bone after cis-platinum, radiation, or both.","volume":"118","author":"Hoistad","year":"1998","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R38-8-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00003446-199910000-00002","article-title":"Effects of chronic tobramycin treatment on distortion product otoacoustic emissions.","volume":"20","author":"Katbamna","year":"1999","journal-title":"Ear Hear"},{"key":"R39-8-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0378-5955(80)90064-7","article-title":"Cochlear mechanics: Implications of electrophysiological and acoustical observations.","volume":"2","author":"Kim","year":"1980","journal-title":"Hear Res"},{"key":"R40-8-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/00016489609137705","article-title":"Distortion product otoacoustic emission test of sensorineural hearing loss: Performance regarding sensitivity, specificity and receiver operating characteristics.","volume":"116","author":"Kim","year":"1996","journal-title":"Acta Otolaryngol"},{"key":"R41-8-20210128","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2006.07.9723","article-title":"Early changes in auditory function as a result of platinum chemotherapy: Use of extended high frequency audiometry and evoked distortion product otoacoustic emissions.","volume":"25","author":"Knight","year":"2007","journal-title":"J Clin Oncol"},{"key":"R42-8-20210128","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/019459988108900226","article-title":"Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum.","volume":"89","author":"Komune","year":"1981","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R43-8-20210128","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/archotol.1981.00790460006003","article-title":"Potentiating effects of cisplatin and ethacrynic acid in ototoxicity.","volume":"107","author":"Komune","year":"1981","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R44-8-20210128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0196-0709(83)80003-9","article-title":"Ototoxicity of cis-dichlorodiammine platinum (II) in guinea pigs.","volume":"4","author":"Konishi","year":"1983","journal-title":"Am J Otolaryngol"},{"key":"R45-8-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3766\/jaaa.21.5.3","article-title":"Evaluation of audiometric threshold shift criteria for ototoxicity monitoring.","volume":"21","author":"Konrad-Martin","year":"2010","journal-title":"J Am Acad Audiol"},{"key":"R46-8-20210128","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1121\/1.1370356","article-title":"Sources of distortion product otoacoustic emissions revealed by suppression experiments and inverse fast Fourier transforms in normal ears.","volume":"109","author":"Konrad-Martin","year":"2001","journal-title":"J Acoust Soc Am"},{"key":"R47-8-20210128","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1121\/1.423054","article-title":"The level and growth behavior of the 2 f1-f2 distortion product otoacoustic emission and its relationship to auditory sensitivity in normal hearing and cochlear hearing loss.","volume":"103","author":"Kummer","year":"1998","journal-title":"J Acoust Soc Am"},{"key":"R48-8-20210128","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/00016488609108609","article-title":"Cis-platin ototoxicity in previously noise-exposed guinea pigs.","volume":"101","author":"Laurell","year":"1986","journal-title":"Acta Otolaryngol"},{"key":"R49-8-20210128","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/01050398809070712","article-title":"Ototoxicity of cisplatin in gynecological cancer patients.","volume":"17","author":"Laurell","year":"1988","journal-title":"Scand Audiol"},{"key":"R50-8-20210128","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1288\/00005537-199007000-00008","article-title":"High-dose cisplatin treatment: Hearing loss and plasma concentrations.","volume":"100","author":"Laurell","year":"1990","journal-title":"Laryngoscope"},{"key":"R51-8-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0006-341X.2002.00001.x","article-title":"Model-checking techniques based on cumulative residuals.","volume":"58","author":"Lin","year":"2002","journal-title":"Biometrics"},{"key":"R52-8-20210128","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/00016488509108921","article-title":"Cis-diaminedichloro platinum ototoxicity. An experimental study.","volume":"99","author":"Marco-Algarra","year":"1985","journal-title":"Acta Otolarynogol"},{"key":"R53-8-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0378-5955(87)90049-9","article-title":"Acoustic distortion products in rabbit ear canal. II. Sites of origin revealed by suppression contours and pure-tone exposures.","volume":"28","author":"Martin","year":"1987","journal-title":"Hear Res"},{"key":"R54-8-20210128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1121\/1.3073734","article-title":"Steep and shallow phase gradient distortion product otoacoustic emissions arising basal to the primary tones.","volume":"125","author":"Martin","year":"2009","journal-title":"J Acoust Soc Am"},{"key":"R55-8-20210128","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1121\/1.3353121","article-title":"Evidence for basal distortion-product otoacoustic emission components.","volume":"127","author":"Martin","year":"2010","journal-title":"J Acoust Soc Am"},{"key":"R56-8-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/03005364000000004","article-title":"Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects.","volume":"31","author":"Mulheran","year":"1997","journal-title":"Br J Audiol"},{"key":"R57-8-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/00016488209130876","article-title":"Ototoxicity of the anticancer drug cisplatin. An experimental study.","volume":"93","author":"Nakai","year":"1982","journal-title":"Acta Otolaryngol"},{"key":"R58-8-20210128","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1121\/1.423876","article-title":"Comparison between intensity and pressure as measures of sound level in the ear canal.","volume":"104","author":"Neely","year":"1998","journal-title":"J Acoust Soc Am"},{"key":"R59-8-20210128","article-title":"EMAV: Otoacoustic emission averager. Tech Memo No. 17.","author":"Neely","year":"1993"},{"key":"R60-8-20210128","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.2217\/14622416.9.10.1521","article-title":"Genetic variants associated with cisplatin-induced ototoxicity.","volume":"9","author":"Oldenburg","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R61-8-20210128","first-page":"76","article-title":"Decreased hearing after combined modality therapy for head and neck cancer.","volume":"27","author":"Pearson","year":"2006","journal-title":"Am J Otolaryngol Head Neck Med Surg"},{"key":"R62-8-20210128","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/00001813-200009000-00007","article-title":"Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.","volume":"11","author":"Peters","year":"2000","journal-title":"Anticancer Drugs"},{"key":"R63-8-20210128","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1200\/JCO.2006.10.077","article-title":"Relationship between cisplatin administration and the development of ototoxicity.","volume":"24","author":"Rademaker-Lakhai","year":"2006","journal-title":"J Clin Oncol"},{"key":"R64-8-20210128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/106652702760138592","article-title":"A paradigm for class prediction using gene expression profiles.","volume":"9","author":"Radmacher","year":"2002","journal-title":"Comput Biol"},{"key":"R65-8-20210128","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/AUD.0b013e318181ad99","article-title":"Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.","volume":"29","author":"Reavis","year":"2008","journal-title":"Ear Hear"},{"key":"R66-8-20210128","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/hn.1999.v121.a101567","article-title":"Effects of cis-platinum chemotherapy on otoacoustic emissions: The development of an objective screening protocol.","volume":"121","author":"Ress","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R67-8-20210128","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/1097-0142(19851015)56:8<1934::AID-CNCR2820560807>3.0.CO;2-F","article-title":"Ototoxicity of low- and moderate-dose cisplatin.","volume":"56","author":"Schaefer","year":"1985","journal-title":"Cancer"},{"key":"R68-8-20210128","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1121\/1.2931953","article-title":"Influence of in situ, sound-level calibration on distortion-product otoacoustic emission variability.","volume":"124","author":"Scheperle","year":"2008","journal-title":"J Acoust Soc Am"},{"key":"R69-8-20210128","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0030-6665(20)30766-0","article-title":"Ototoxicity of chemotherapeutic agents.","volume":"26","author":"Schweitzer","year":"1993","journal-title":"Otolaryngol Clin North Am"},{"key":"R70-8-20210128","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/019459988409200109","article-title":"Ototoxic and nephrotoxic effects of combined treatment with cis-diamminedichloroplatinum and kanamycin in the guinea pig.","volume":"92","author":"Schweitzer","year":"1984","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R71-8-20210128","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1121\/1.426948","article-title":"Evoked otoacoustic emissions arise by two fundamentally different mechanisms: A taxonomy for mammalian OAEs.","volume":"105","author":"Shera","year":"1999","journal-title":"J Acoust Soc Am"},{"key":"R72-8-20210128","first-page":"403","article-title":"Otoacoustic Emissions: Clinical Applications Third Edition","author":"Siegel","year":"2007"},{"key":"R73-8-20210128","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0378-5955(94)90106-6","article-title":"Sound calibration and distortion-product otoacoustic emissions at high frequencies.","volume":"80","author":"Siegel","year":"1994","journal-title":"Hear Res"},{"key":"R74-8-20210128","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.1200\/JCO.2005.02.8712","article-title":"Roadmap for developing and validating therapeutically relevant genomic classifiers.","volume":"23","author":"Simon","year":"2005","journal-title":"J Clin Oncol"},{"key":"R75-8-20210128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-5876(01)00455-4","article-title":"Evoked otoacoustic emissions\u2014An approach for monitoring cisplatin induced ototoxicity in children.","volume":"59","author":"Stavroulaki","year":"2001","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R76-8-20210128","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archotol.128.2.150","article-title":"Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis.","volume":"128","author":"Stavroulaki","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"R77-8-20210128","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1121\/1.416207","article-title":"Toward optimizing the clinical utility of distortion product otoacoustic emission measurements.","volume":"100","author":"Stover","year":"1996","journal-title":"J Acoust Soc Am"},{"key":"R78-8-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-5955(00)00182-9","article-title":"Acute changes in cochlear potentials due to cisplatin.","volume":"149","author":"Tsukasaki","year":"2000","journal-title":"Hear Res"},{"issue":"2","key":"R79-8-20210128","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/000348948809700208","article-title":"High frequency audiometry in prospective clinical research of ototoxicity due to platinum derivatives.","volume":"97","author":"van der Hulst","year":"1988","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R80-8-20210128","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.heares.2005.03.023","article-title":"The cochlear targets of cisplatin: An electrophysiological and morphological time-sequence study.","volume":"205","author":"van Ruijven","year":"2005","journal-title":"Hear Res"},{"key":"R81-8-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0277-5379(83)90398-X","article-title":"Ototoxicity of cis-diamminedichloroplatinum (II): Influence of dose, schedule and mode of administration.","volume":"19","author":"Vermorken","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"R82-8-20210128","first-page":"199","article-title":"Clinical Aspects of Hearing","author":"Whitehead","year":"1996"}],"container-title":["Ear &amp; Hearing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AUD.0b013e3181e8b6a7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:28:58Z","timestamp":1786040938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003446-201102000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/aud.0b013e3181e8b6a7","relation":{},"ISSN":["0196-0202"],"issn-type":[{"value":"0196-0202","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}